Insider Shareholders with Direct Ownership of Olema Pharmaceuticals, Inc. (OLMA)
This section provides a comprehensive overview of the insiders with direct ownership of Olema Pharmaceuticals, Inc. (OLMA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Olema Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
1,725,406 | 0 | 1,725,406 $15 Million | 1 |
Nov 23, 2020
Added 20.76%
|
|
Peter J. Kushner
CHIEF SCIENTIFIC OFFICER |
502,392 | 0 | 1,431,672 $12.4 Million | 2 |
Nov 23, 2020
Added 8.33%
|
| 259,846 | 422,855 | 741,259 $6.44 Million | 42 |
Dec 22, 2025
Reduced 0.39%
|
|
|
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF |
218,472 | 140,436 | 542,881 $4.72 Million | 14 |
Dec 19, 2025
Reduced 1.63%
|
|
Bvf Partners L P
Director |
8,797,617 | 3,789,704 | 347,970 $3.02 Million | 6 |
Jan 10, 2025
Reduced 6.13%
|
|
Shane William Charles Kovacs
CH. OPERATING & FINANCIAL OFF. |
578,680 | 353,901 | 243,549 $2.12 Million | 14 |
Dec 08, 2025
Reduced 23.54%
|
|
Sean Bohen
President and CEO |
396,649 | 185,227 | 237,650 $2.07 Million | 19 |
Dec 26, 2025
Reduced 3.45%
|
|
Frank Mccormick
Director |
152,891 | 0 | 191,113 $1.66 Million | 1 |
Nov 23, 2020
Added 44.44%
|
| 83,876 | 0 | 83,876 $728,882 | 1 |
Sep 16, 2020
Added 50.0%
|
|
|
Naseem Zojwalla
Chief Medical Officer |
293,160 | 311,870 | 4,488 $39,000 | 18 |
Dec 23, 2025
Reduced 95.68%
|
|
Kinney Horn
Chief Business Officer |
132,692 | 132,692 | 2,458 $21,360 | 22 |
Mar 10, 2022
Reduced 68.12%
|
| 264,800 | 264,800 | 0 $0 | 2 |
Dec 19, 2025
Reduced 100.0%
|
|
| 35,868 | 35,868 | 0 $0 | 2 |
Nov 25, 2025
Reduced 100.0%
|
|